Trademarkia Logo

Australia

AU$
Trademark Search
REJVEDI

View On IPO.GOV.AU

REJVEDI
Protected: Registered/protected

Last updated on 23 Jan 2024

Owner Info

Syndax Pharmaceuticals, Inc.

35 Gatehouse Drive, Building D, Floor 3

Waltham MA 02451, UNITED STATES OF AMERICA

Serial Number

2378919 filed on 14 Jul 2023

Correspondent

John Paul Oleksiuk Cooley LLP

1299 Pennsylvania Ave NW,,

Suite 700,

UNITED STATES OF AMERICA

REJVEDI

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of cancer.

Class [042]
Research and development of pharmaceuticals for the treatment of cancer; medical and scientific research services in the field of cancer treatment.

Class [044]
Providing information in the field of cancer treatment; information about the diagnosis and treatment of cancer provided via web links to third party Read More

Mark Details

Serial Number

2378919

Registered On

14 Jul 2023

Renewal On

14 Jul 2033

Mark Type

WORD

Priority Claim (Convention Details)

Date

19 Jan 2023

Mark Type

US

Legal History

Show more

Status DateAction Taken
23rd Jan 2024International Registration in Australia Protected After Adverse (Amendments) correspondence sent
22nd Jan 2024International Registration in Australia Protected After Adverse (Amendments) correspondence sent
22nd Jan 2024IP Right Registration Published
22nd Jan 2024Status change to Registered/Protected
15th Nov 2023Application Accepted correspondence sent
14th Nov 2023Application Accepted correspondence sent
14th Nov 2023IP Right has been Examined
14th Nov 2023IP Right Acceptance Published
14th Nov 2023Status change to Accepted
14th Nov 2023IP Right Goods and Services Items updated